Technology area: Biotechnology & Pharmaceuticals
51 pending office actions • 37 clients • 49 examiners • 42 art units • 0 of 51 (0%) have an AI response strategy ready
Patent Law Works, LLP reports 52 pending office actions in Biotechnology & Pharmaceuticals and 1787 career applications. The active response docket is substantial, and the application history provides a broad base for interpreting the reported prosecution measures within this technical area.
The resolved allowance rate is 87.59%, while the average is 3.63 office actions per allowance. The allowance rate indicates that a large share of resolved applications reached allowance, and the action average indicates that those outcomes generally followed multiple examination exchanges. The combination is relevant to practitioners assessing both portfolio scale and the response resources associated with prosecution.
Based on the USPTO statutory response window for each pending office action. 20 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 20 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §101 + other | 11 (22%) |
| §103 only | 8 (16%) |
| §102 only | 2 (4%) |
| §112 only | 9 (18%) |
| Double-patenting only | 1 (2%) |
| Double-patenting + other | 4 (8%) |
| Multi-statute (no §101) | 15 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SULLIVAN, THOMAS J | 2 | 27.5% | +21.7% |
| LI, RUIXIANG | 2 | 59.5% | +18.7% |
| FURTADO, WINSTON RAHUL | 1 | 18.9% | +22.9% |
| THOMPSON, KENNETH L | 1 | 87.4% | +6.8% |
| CHANNAVAJJALA, SRIRAMA T | 1 | 74.6% | +32.3% |
| AKOGYERAM II, NICHOLAS A | 1 | 26.4% | +29.2% |
| KANAAN, LIZA TONY | 1 | 23.4% | +31.5% |
| DEMEREE, CHRISTOPHER R | 1 | 68.9% | +14.2% |
| PURDY, KYLE A | 1 | 41.0% | +35.7% |
| CHANG, AUDREY Y | 1 | 46.6% | +20.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19294816 | Method and System for Controlling a Plurality of Drill Rigs | THOMPSON, KENNETH L | 9d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18688085 | Methods for Isolation of Lipid-Disc Compositions and Uses Thereof | STEVENS, MARK V | 67d overdue |
| 18575056 | A Flexible and Stretchable Cover for Attaching a Component to a Patch | CHA, CASEY GEORGE | 4d overdue |
| 18552827 | Vaccine Compositions for Trypanosomatids | GRASER, JENNIFER E | 3d overdue |
| 19067529 | AUTOMATED MEDICATION REVIEW RECONCILIATION | KANAAN, LIZA TONY | 28d |
| 18255433 | AN LTBR AGONIST IN COMBINATION THERAPY AGAINST CANCER | MACFARLANE, STACEY NEE | 29d |
| 18004719 | METHODS FOR IDENTIFYING CORONAVIRUS CROSS-REACTING ANTIBODIES | WANG, RUIXUE | 33d |
| 18569805 | Compositions Comprising Microbes and Methods of Use and Making Thereof | CRUM, MARY ABOU NADER | 47d |
| 18805393 | Predicting Climate Event Occurrences and Damage Using Property Features and Artificial Intelligence | KWONG, CHO YIU | 70d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18359483 | PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF | LI, RUIXIANG | 23d overdue |
| 19067529 | AUTOMATED MEDICATION REVIEW RECONCILIATION | KANAAN, LIZA TONY | 28d |
| 19299221 | IMPROVED AI HYBRID CARE MODELS FOR COORDINATING MEDICATION ASSISTED TREATMENT | FURTADO, WINSTON RAHUL | — |
| 19270324 | Query-Time Data Sessionization and Analysis | CHANNAVAJJALA, SRIRAMA T | — |
| 19235555 | System and Methods for Creating E-Commerce Virtual Experiences And Integrating Graphical User Interfaces | SULLIVAN, THOMAS J | — |
| 19215220 | System and Methods Integrating Distributed Machine Learning Layers for Processing Multimodal Data Sets in Real Time to Optimize Outcomes | AKOGYERAM II, NICHOLAS A | — |
| 19056706 | System and Methods for Creating E-Commerce Virtual Experiences And Integrating Graphical User Interfaces | SULLIVAN, THOMAS J | — |
| 19099436 | A Food Box | DEMEREE, CHRISTOPHER R | — |
| Art Unit | Apps |
|---|---|
| 3689 | 2 |
| 1653 | 2 |
| 1613 | 2 |
| 1632 | 2 |
| 1635 | 2 |
| 1681 | 2 |
| 1674 | 2 |
| 1643 | 2 |
| 1675 | 2 |
| 3687 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19299221 | IMPROVED AI HYBRID CARE MODELS FOR COORDINATING MEDICATION ASSISTED TREATMENT | Anonymous Health | FURTADO, WINSTON RAHUL | 3687 | §101 | Final Rejection | — | Pending | Aug 13, 2025 |
| 19294816 | Method and System for Controlling a Plurality of Drill Rigs | Technological Resources Pty Limited | THOMPSON, KENNETH L | 3676 | DP | Final Rejection | 9d overdue | Pending | Aug 08, 2025 |
| 19270324 | Query-Time Data Sessionization and Analysis | Imply Data, Inc. | CHANNAVAJJALA, SRIRAMA T | 2154 | §103 | Final Rejection | — | Pending | Jul 15, 2025 |
| 19235555 | System and Methods for Creating E-Commerce Virtual Experiences And Integrating Graphical User Interfaces | Zelig Technology, LLC | SULLIVAN, THOMAS J | 3689 | §103§112 | Non-Final OA | — | Pending | Jun 11, 2025 |
| 19215220 | System and Methods Integrating Distributed Machine Learning Layers for Processing Multimodal Data Sets in Real Time to Optimize Outcomes | Cormetrix Inc. | AKOGYERAM II, NICHOLAS A | 3686 | §101§103§112 | Non-Final OA | — | Pending | May 21, 2025 |
| 19067529 | AUTOMATED MEDICATION REVIEW RECONCILIATION | Kaiser Foundation Hospitals | KANAAN, LIZA TONY | 3683 | §101§103 | Final Rejection | 28d | Pending | Feb 28, 2025 |
| 19056706 | System and Methods for Creating E-Commerce Virtual Experiences And Integrating Graphical User Interfaces | Zelig Technology, LLC | SULLIVAN, THOMAS J | 3689 | §101§103 | Non-Final OA | — | Pending | Feb 18, 2025 |
| 19099436 | A Food Box | Tria Pte. Ltd. | DEMEREE, CHRISTOPHER R | 3734 | §102§112 | Non-Final OA | — | Pending | Jan 28, 2025 |
| 18997284 | Species-Specific Tissue Culture Medium for the Propagation of Cells | SymbioCellTech, LLC | PURDY, KYLE A | 1611 | §103 | Non-Final OA | — | Pending | Jan 21, 2025 |
| 18991000 | Head-Mounted Display with Volume Substrate-Guided Holographic Continuous Lens Optics | Luminit LLC | CHANG, AUDREY Y | 2872 | §102§103§112 | Non-Final OA | — | Pending | Dec 20, 2024 |
| 18957277 | Dynamic Batch Limit Validation | Id Business Solutions, Inc. | LITTLE, VANCE M | 2494 | §101§103 | Final Rejection | 75d | Pending | Nov 22, 2024 |
| 18868632 | Automated Toilet System | Gmat Ventures, LLC | DEERY, ERIN LEAH | 3754 | §103§112 | Non-Final OA | — | Pending | Nov 22, 2024 |
| 18925663 | EXTERNAL SENSOR ARRAY HOUSING FOR EQUIPMENT OPERATING IN HIGH HAZARD FORESTRY ENVIRONMENTS | Earth Force Technologies, Inc. | WALSH, RYAN D | 2852 | §102§103 | Non-Final OA | — | Pending | Oct 24, 2024 |
| 18847148 | Novel Microbial Composition and Methods of Use Thereof | Pendulum Therapeutics, Inc. | IANNUZO, NATALIE NMN | 1653 | §102§103§112 | Non-Final OA | — | Pending | Sep 13, 2024 |
| 18844200 | Delivery Shaft Assembly for Delivery of an Implant | Istar Medical | ZIMBOUSKI, ARIANA | 3781 | §112 | Non-Final OA | — | Pending | Sep 05, 2024 |
| 18805393 | Predicting Climate Event Occurrences and Damage Using Property Features and Artificial Intelligence | Zesty.Ai, Inc. | KWONG, CHO YIU | 3693 | §101§112 | Non-Final OA | 70d | Pending | Aug 14, 2024 |
| 18835833 | A System For Delivering Food To A Customer And A Method Thereof | Clean Eats & Co. Pte. Ltd. | RODRIGUEZ, JOSEPH C | 3653 | §103§112 | Non-Final OA | — | Pending | Aug 05, 2024 |
| 18725409 | Products and Methods for Improving Plant Growth Features | Aphea.Bio NV | PAGUIO FRISING, MICHELLE F | 1613 | §101§102§112 | Non-Final OA | — | Pending | Jun 28, 2024 |
| 18652767 | Mobile Printing Robot and Printing Methods with Line Printing Pathway Optimization | Dusty Robotics, Inc. | RICHMOND, SCOTT A. | 2853 | §103 | Non-Final OA | — | Pending | May 01, 2024 |
| 18652760 | Mobile Printing Robot Printing Methods and Merging Items to Print | Dusty Robotics, Inc. | POPOVICI, DOV | 2681 | §102§103 | Non-Final OA | — | Pending | May 01, 2024 |
| 18600428 | Means and Methods for Improved Regeneration | UNIVERSITEIT GENT | COLLINS, CYNTHIA E | 1662 | §102§103§112DP | Non-Final OA | — | Pending | Mar 08, 2024 |
| 18688938 | Therapeutic Engineered Microbial Cell Systems and Methods for Treating Conditions in Which Oxalate is Detrimental | Unlocked Labs Inc. | STAVROU, CONSTANTINA E | 1632 | §102 | Non-Final OA | — | Pending | Mar 04, 2024 |
| 18688085 | Methods for Isolation of Lipid-Disc Compositions and Uses Thereof | Vrije Universiteit Brussel | STEVENS, MARK V | 1613 | §101§103§112 | Final Rejection | 67d overdue | Pending | Feb 29, 2024 |
| 18444591 | Grouping and Recommendations System and Method | Renaissance Learning, Inc. | HEWITT II, CALVIN L | 4100 | §101§102§103§112 | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18684059 | Oligonucleotides for Modulating Synaptogyrin-3 Expression | Jay Therapeutics | KONOPKA, CATHERINE ANNE | 1635 | §101§102§103§112DP | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18290670 | Biomarkers for Therapy Response After Immunotherapy | Asylia Diagnostics BV | YU, TIAN NMN | 1681 | §101§102§112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18575056 | A Flexible and Stretchable Cover for Attaching a Component to a Patch | Datwyler Pharma Packaging Belgium NV | CHA, CASEY GEORGE | 3794 | §103§112 | Final Rejection | 4d overdue | Pending | Dec 28, 2023 |
| 18545557 | Secure Payments Using a Mobile Wallet Application | Minkasu, Inc. | XIAO, ZESHENG | 3698 | §103 | Final Rejection | 29d | Pending | Dec 19, 2023 |
| 18570876 | Means and Methods to Regulate Gut Dysbiosis | UNIVERSITEIT GENT | LEWIS, PATRICK T | 1691 | §112 | Final Rejection | — | Pending | Dec 15, 2023 |
| 18569805 | Compositions Comprising Microbes and Methods of Use and Making Thereof | Pendulum Therapeutics, Inc. | CRUM, MARY ABOU NADER | 1657 | §102§112Other | Non-Final OA | 47d | Pending | Dec 13, 2023 |
| 18516777 | Novel Antigen-Binding Chimeric Proteins and Methods and Uses Thereof | Vrije Universiteit Brussel | LI, RUIXIANG | 1674 | §102§112Other | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18497332 | Detection of Cancer in Urine | Nanomed Diagnostics B.V. | GREENE, CAROLYN LEE | 1681 | §102§103 | Final Rejection | — | Pending | Oct 30, 2023 |
| 35522743 | Packaging for foodstuffs | Tria Pte. Ltd. | DIEHL, JOAN ELIZABETH | 2923 | §112 | Non-Final OA | 21d | Pending | Oct 25, 2023 |
| 18553044 | Protein Tyrosine Phosphatases as Biomarkers for Hepatocellular Carcinoma and Uses Thereof | UNIVERSITE LIBRE DE BRUXELLES | FAN, LYNN Y | 1759 | §103§112 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18552827 | Vaccine Compositions for Trypanosomatids | UNIVERSITEIT ANTWERPEN | GRASER, JENNIFER E | 1645 | §103§112 | Final Rejection | 3d overdue | Pending | Sep 27, 2023 |
| 18547111 | Cation-Independent Mannose-6-Phosphate Receptor Binders | UNIVERSITEIT GENT | CHASE, CAROL ANN | 1646 | §102§103§112DP | Non-Final OA | — | Pending | Aug 18, 2023 |
| 18547065 | Harvester Cutter | Ehs Manufacturing Pty Ltd. | WEBB, SUNNY DANIELLE | 3671 | §103 | Non-Final OA | — | Pending | Aug 18, 2023 |
| 18546682 | Inhibition of SLC4A4 in the Treatment of Cancer | Katholieke Universiteit Leuven | HAM, JIEUN | 1643 | §103DP | Final Rejection | — | Pending | Aug 16, 2023 |
| 18359483 | PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF | The Board Of Trustees Of The Leland Stanford Junior University | LI, RUIXIANG | 1674 | §112Other | Final Rejection | 23d overdue | Pending | Jul 26, 2023 |
| 18259141 | NON-BLOCKING HUMAN CCR8 BINDERS | Vrije Universiteit Brussel | WANG, CHANG YU | 1675 | §112 | Final Rejection | 41d | Pending | Jun 23, 2023 |
| 18258495 | CARDIOMYOCYTE-DERIVED NUCLEIC ACID REGULATORY ELEMENTS AND METHODS AND USE THEREOF | Vrije Universiteit Brussel | SHIN, DANA H | 1635 | §112 | Final Rejection | — | Pending | Jun 20, 2023 |
| 18258102 | G PROTEIN PEPTIDOMIMETICS | Vrije Universiteit Brussel | BOWLES, DAVID PAUL | 1654 | §112 | Final Rejection | 4d overdue | Pending | Jun 16, 2023 |
| 18255433 | AN LTBR AGONIST IN COMBINATION THERAPY AGAINST CANCER | Vrije Universiteit Brussel | MACFARLANE, STACEY NEE | 1675 | §103§112 | Final Rejection | 29d | Pending | Jun 01, 2023 |
| 18005119 | DELIVERY SHAFT ASSEMBLY FOR DELIVERY OF AN IMPLANT | Istar Medical | MANNAN, MIKAIL A | 3774 | §103 | Final Rejection | 8d overdue | Pending | Jan 11, 2023 |
| 18004719 | METHODS FOR IDENTIFYING CORONAVIRUS CROSS-REACTING ANTIBODIES | Leyden Laboratories B.V. | WANG, RUIXUE | 1672 | §101§103§112 | Final Rejection | 33d | Pending | Jan 09, 2023 |
| 17801921 | Leucine-Rich Repeat Kinase 2 Allosteric Modulators | DEUTSCHES ZENTRUM FÜR NEURODEGENERATIVE ERKRANKUNGEN E.V. | BRISTOL, LYNN ANNE | 1643 | §112 | Final Rejection | 23d overdue | Pending | Aug 24, 2022 |
| 17787880 | Compositions Comprising Microbes and Methods of Use and Making Thereof | Pendulum Therapeutics, Inc. | EIX, EMILY FAY | 1653 | §102Other | Final Rejection | — | Pending | Jun 21, 2022 |
| 17620208 | CROSSLINKABLE HYDROGEL COMPOSITIONS | ETH ZÜRICH | ARMSTRONG, SUSANNAH SIPPLE | 1616 | §103DP | Final Rejection | — | Pending | Dec 17, 2021 |
| 17607334 | CHIMERIC PROTEINS AND METHODS TO SCREEN FOR COMPOUNDS AND LIGANDS BINDING TO GPCRS | Confo Therapeutics N.V. | REYNOLDS, FRED H | 1658 | §112 | Final Rejection | 98d overdue | Pending | Oct 28, 2021 |
| 17604284 | MICROBIAL COMPOSITIONS AND METHODS FOR GREATER TOLERABILITY AND PROLONGED SHELF LIFE | Pendulum Therapeutics, Inc. | SPANGLER, JOSEPH RANKIN | 1656 | §103Other | Final Rejection | 104d overdue | Pending | Oct 15, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial87.6% of resolved applications prosecuted by Patent Law Works, LLP were allowed, across 1,787 applications in USPTO records.
3.63 office actions per allowed application on average.
51 pending office actions as of October 2026, for 37 clients, before 49 examiners in 42 art units.
